Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | zimeldine | 5311054 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | zimeldine | 5311054 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | zimeldine | 5311054 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | zimeldine | 5311054 | drug-path |
| Asthma | R-HSA-444620 | map05310 | zimeldine | 5311054 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | zimeldine | 5311054 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | zimeldine | 5311054 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | zimeldine | 5311054 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | zimeldine | 5311054 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | zimeldine | 5311054 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | zimeldine | 5311054 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | zimeldine | 5311054 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | zimeldine | 5311054 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | zimeldine | 5311054 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | metanephrine | 21100 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | metanephrine | 21100 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | metanephrine | 21100 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | metanephrine | 21100 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | metanephrine | 21100 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | metanephrine | 21100 | drug-path |